CA2824724C — Methods and systems for spatially identifying abnormal cells
Assigned to Lumicell Inc · Expires 2020-07-21 · 6y expired
What this patent protects
A method for identifying abnormal cells compares healthy tissue fluorescence intensity with abnormal tissue fluorescence intensity to determine a threshold fluorescence intensity to discriminate between abnormal tissue and healthy tissue of a patient. At least one of a healthy ti…
USPTO Abstract
A method for identifying abnormal cells compares healthy tissue fluorescence intensity with abnormal tissue fluorescence intensity to determine a threshold fluorescence intensity to discriminate between abnormal tissue and healthy tissue of a patient. At least one of a healthy tissue signal and abnormal tissue signal are used to determine the desired threshold. A tumor bed is illuminated with an excitation light. Fluorescence signals are detected from the tumor bed and the intensity of the fluorescence signal of the tumor bed is compared to the threshold fluorescence intensity to identify abnormal cells.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.